BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 14606264)

  • 21. Antimycobacterial activity of econazole against multidrug-resistant strains of Mycobacterium tuberculosis.
    Ahmad Z; Sharma S; Khuller GK; Singh P; Faujdar J; Katoch VM
    Int J Antimicrob Agents; 2006 Dec; 28(6):543-4. PubMed ID: 17101262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antituberculosis agents. III. In vitro evaluation of antimycobacterial activity and cytotoxicity of some N-piperazinyl quinolone derivatives.
    Foroumadi A; Soltani F; Emami S; Davood A
    Boll Chim Farm; 2002; 141(3):247-9. PubMed ID: 12197426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and in vitro antimycobacterial activity of 3-substituted 5-hydroxy-5-trifluoro[chloro]methyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazoles.
    Almeida da Silva PE; Ramos DF; Bonacorso HG; de la Iglesia AI; Oliveira MR; Coelho T; Navarini J; Morbidoni HR; Zanatta N; Martins MA
    Int J Antimicrob Agents; 2008 Aug; 32(2):139-44. PubMed ID: 18571384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A study of INH 0.1 microgram/ml resistant M. tuberculosis strains assessed by BrothMIC MTB-1 method].
    Yoshida H; Ano H; Ishida C; Tanigawa N; Kikui M; Takashima T; Tsuyuguchi I
    Kekkaku; 2002 Jul; 77(7):533-5. PubMed ID: 12187818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity.
    Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK
    Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis.
    Shakya N; Srivastav NC; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2010 May; 53(10):4130-40. PubMed ID: 20420370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro antimycobacterial activity of a new quinolone, T-3761].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity.
    Barbachyn MR; Hutchinson DK; Brickner SJ; Cynamon MH; Kilburn JO; Klemens SP; Glickman SE; Grega KC; Hendges SK; Toops DS; Ford CW; Zurenko GE
    J Med Chem; 1996 Feb; 39(3):680-5. PubMed ID: 8576910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Resistance testing of M. avium-intracellulare and M. tuberculosis of AIDS patients with new drugs and drug combinations].
    Mauch H; Reichert B; Ruf B; Brehmer W
    Pneumologie; 1990 Feb; 44 Suppl 1():504-6. PubMed ID: 2114636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimal inhibitory concentrations of lomefloxacin and minocycline against drug-sensitive and drug-resistant isolates of M. tuberculosis compared on L-J and 7H11 media.
    Kamala T; Herbert D; Venkatesan P; Paramasivan CN
    Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):375-8. PubMed ID: 9401493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and in vitro evaluation of benzylsulfanyl benzoxazole derivatives as potential antituberculosis agents.
    Klimesová V; Kocí J; Waisser K; Kaustová J; Möllmann U
    Eur J Med Chem; 2009 May; 44(5):2286-93. PubMed ID: 18694614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of bacteriostatic and bactericidal activity of isoniazid and ethionamide against Mycobacterium avium and Mycobacterium tuberculosis.
    Heifets LB; Lindholm-Levy PJ; Flory M
    Am Rev Respir Dis; 1991 Feb; 143(2):268-70. PubMed ID: 1899326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activities of the newly synthesised ER-2 against clinical isolates of Mycobacterium tuberculosis susceptible or resistant to antituberculosis drugs.
    Rao SS; Raghunathan R; Ekambaram R; Raghunathan M
    Int J Antimicrob Agents; 2009 Nov; 34(5):451-3. PubMed ID: 19625168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
    Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
    J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors.
    Shakya N; Srivastav NC; Bhavanam S; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    Bioorg Med Chem; 2012 Jul; 20(13):4088-97. PubMed ID: 22664188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H(37)Rv, MDR and NRP Mycobacterium tuberculosis.
    Figueiredo R; Moiteiro C; Medeiros MA; da Silva PA; Ramos D; Spies F; Ribeiro MO; Lourenço MC; Júnior IN; Gaspar MM; Cruz ME; Curto MJ; Franzblau SG; Orozco H; Aguilar D; Hernandez-Pando R; Costa MC
    Bioorg Med Chem; 2009 Jan; 17(2):503-11. PubMed ID: 19119013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and evaluation of in vitro antimycobacterial activity of some 5-(5-nitro-2-thienyl)-2-(piperazinyl, piperidinyl and morpholinyl)-1,3,4-thiadiazole derivatives.
    Foroumadi A; Soltani F; Rezaee MA; Moshafi MH
    Boll Chim Farm; 2003 Nov; 142(9):416-9. PubMed ID: 14971311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis.
    De Logu A; Palchykovska LH; Kostina VH; Sanna A; Meleddu R; Chisu L; Alexeeva IV; Shved AD
    Int J Antimicrob Agents; 2009 Mar; 33(3):223-9. PubMed ID: 19070992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro antimycobacterial activity of a new quinolone, NM394].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1993 Aug; 68(8):517-20. PubMed ID: 8397311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.